Huntington National Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Buy |
676
+378
| +127% | +$57.4K | ﹤0.01% | 943 |
|
|
2025
Q1 | $44.9K | Sell |
298
-2
| -0.7% | -$301 | ﹤0.01% | 1224 |
|
|
2024
Q4 | $55.4K | Buy |
300
+164
| +121% | +$30.3K | ﹤0.01% | 1154 |
|
|
2024
Q3 | $26.8K | Sell |
136
-111
| -45% | -$21.9K | ﹤0.01% | 1414 |
|
|
2024
Q2 | $51K | Sell |
247
-3
| -1% | -$620 | ﹤0.01% | 1111 |
|
|
2024
Q1 | $67.7K | Buy |
250
+32
| +15% | +$8.67K | ﹤0.01% | 1009 |
|
|
2023
Q4 | $51.5K | Sell |
218
-50
| -19% | -$11.8K | ﹤0.01% | 1067 |
|
|
2023
Q3 | $52.5K | Sell |
268
-73
| -21% | -$14.3K | ﹤0.01% | 1024 |
|
|
2023
Q2 | $71.7K | Buy |
341
+122
| +56% | +$25.7K | ﹤0.01% | 928 |
|
|
2023
Q1 | $44.2K | Buy |
219
+17
| +8% | +$3.43K | ﹤0.01% | 1042 |
|
|
2022
Q4 | $44K | Buy |
202
+13
| +7% | +$2.83K | ﹤0.01% | 1045 |
|
|
2022
Q3 | $37K | Buy |
189
+66
| +54% | +$12.9K | ﹤0.01% | 1077 |
|
|
2022
Q2 | $26K | Buy |
123
+11
| +10% | +$2.33K | ﹤0.01% | 1221 |
|
|
2022
Q1 | $32K | Sell |
112
-11
| -9% | -$3.14K | ﹤0.01% | 1203 |
|
|
2021
Q4 | $46K | Sell |
123
-1
| -0.8% | -$374 | ﹤0.01% | 1094 |
|
|
2021
Q3 | $51K | Sell |
124
-53
| -30% | -$21.8K | ﹤0.01% | 964 |
|
|
2021
Q2 | $65K | Buy |
177
+55
| +45% | +$20.2K | ﹤0.01% | 867 |
|
|
2021
Q1 | $35K | Buy |
122
+67
| +122% | +$19.2K | ﹤0.01% | 940 |
|
|
2020
Q4 | $14K | Buy |
55
+54
| +5,400% | +$13.7K | ﹤0.01% | 1215 |
|
|
2020
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1562 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 1550 |
|
|
2020
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 1595 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1691 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 1564 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1615 |
|
|
2019
Q1 | – | Sell |
-1
| Closed | – | – | 1599 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 1687 |
|
|
2018
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1705 |
|